comparemela.com

Latest Breaking News On - Multidisciplinary digital publishing institute - Page 1 : comparemela.com

How to Protect Yourself During a Heat Wave

The first major heat wave of the season has brought scorching temperatures in the three-digit threshold across the Southwestern U.S. this week.

Idaho
United-states
Oregon
California
Texas
Wyoming
Phoenix
Arizona
Utah
Colorado
Nevada
New-mexico

Tobacco funded research: how even journals with bans find it hard to stem the tide of publications

Tobacco funded research: how even journals with bans find it hard to stem the tide of publications
bmj.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bmj.com Daily Mail and Mail on Sunday newspapers.

Japan
United-states
Denmark
Maastricht
Limburg
Netherlands
London
City-of
United-kingdom
Stanford-university
California
Switzerland

Central and eastern Europe bites back at predatory publishers

Central and eastern Europe bites back at predatory publishers
sciencebusiness.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sciencebusiness.net Daily Mail and Mail on Sunday newspapers.

France
Romania
Belgium
Poland
Czech-republic
United-kingdom
Croatia
Russia
Ukraine
Spain
Soviet
Russian

Haims: Olive oil is at the heart of a high-quality diet

Last month I read an interesting article published in the Journal Of The American Medical Association titled, “Consumption of Olive Oil and Diet Quality and Risk of Dementia-Related Death.” The article claimed that “higher olive.

United-states
American
Judson-haims
American-heart-association
Health-professionals-study
American-medical-association
Heart-foundation
Cardiometabolic-health-scientific-sessions
Nurse-health-study
Multidisciplinary-digital-publishing-institute
Consumption-of-olive-oil
National-institutes-of-health

Study exposes high HIV drugs resistance

Local and international scientists have recorded a 27 percent resistance to anti-HIV drugs dolutegravir, exceeding levels initially observed during its trials. Before the World Health Organisation approved the drugs over a decade ago, resistance ranged from 3.9 percent to 8.6 percent, records show. Titled Virological Findings and Treatment Outcomes of Cases That Developed Dolutegravir Resistance

Malawi
South-africa
Malawian
Bilaal-matola
Chifundo-chipungu
Pachawo-bisani
National-aids-commission
University-of-the-witwatersrand
Malawi-national
Kamuzu-college-of-health-sciences
Treatment-programme
University-of-washington

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.